Literature DB >> 8032684

An activator element within the preprotachykinin-A promoter.

C F Morrison1, J McAllister, S P Dobson, P K Mulderry, J P Quinn.   

Abstract

The rat Preprotachykinin-A promoter (PPT) directs high levels of expression in dorsal root ganglia (DRG) neurons in culture either endogenously or when linked to a receptor construct. It is not active in any of the established tissue culture cell lines which we have analyzed. To search for transcriptional regulators within this promoter we have started to dissect the promoter into individual elements to determine their function. A DNA element which had previously been suggested to regulate transcription from DNA sequence analysis of the rat PPT promoter occurs at position -200 relative to the major start of transcription within the PPT promoter. The equivalent element from the bovine PPT promoter had previously been proposed to be a cAMP responsive element (CRE). The sequence of this enhancer has similarities with both the AP1 and CRE DNA consensus sequences. We have demonstrated that one copy of this rat PPT element linked to a heterologous basal promoter will enhance transcription in HeLa and PC12 cell lines as well as adult rat DRG neurons grown in culture. It is also demonstrated that the rat PPT element will bind proteins in HeLa nuclear extract distinct from those binding to the well-characterized Gibbon Ape Leukemia Virus (GALV) AP1 or somatostatin CRE sites by gel retardation analysis. This PPT element, when cloned in a heterologous reporter construct, although showing properties of both AP1 and CRE elements, was functionally distinguished from both the somatostatin CRE element and the GALV AP1 enhancer when these elements were tested in the same reporter construct. This PPT element has a constitutive level of activity in adult rat DRG neurons, which is fivefold higher than that driven by the reporter construct promoter. It is also significantly different from the same reporter construct linked to the somatostatin CRE and analyzed in DRG neurons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032684     DOI: 10.1006/mcne.1994.1018

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  6 in total

1.  Novel cell lines for the analysis of preprotachykinin A gene expression identify a repressor domain 3' of the major transcriptional start site.

Authors:  C E Fiskerstrand; P Newey; B Ebrahimi; L Gerrard; P Harrison; G P McGregor; J P Quinn
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

2.  E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer.

Authors:  J M Coulson; C E Fiskerstrand; P J Woll; J P Quinn
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

3.  An upstream stimulatory factor (USF) binding motif is critical for rat preprotachykinin-A promoter activity in PC12 cells.

Authors:  J M Paterson; C F Morrison; S C Mendelson; J McAllister; J P Quinn
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

4.  Lithium chloride regulation of the substance P encoding preprotachykinin a, Tac1 gene in rat hippocampal primary cells.

Authors:  Kate Haddley; Eleanor Mary Spencer; Sylvia Argiroula Vasiliou; Mark Howard; Thimmasettappa Thippeswamy; Vivien Jill Bubb; John P Quinn
Journal:  J Mol Neurosci       Date:  2010-08-06       Impact factor: 3.444

5.  Long-range regulatory synergy is required to allow control of the TAC1 locus by MEK/ERK signalling in sensory neurones.

Authors:  Lynne Shanley; Scott Davidson; Marissa Lear; Anil Kumar Thotakura; Iain Joseph McEwan; Ruth A Ross; Alasdair MacKenzie
Journal:  Neurosignals       Date:  2010-12-16

6.  A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.

Authors:  Camila Guindalini; Mark Howard; Kate Haddley; Ronaldo Laranjeira; David Collier; Nik Ammar; Ian Craig; Colin O'Gara; Vivian J Bubb; Tiffany Greenwood; John Kelsoe; Phil Asherson; Robin M Murray; Adauto Castelo; John P Quinn; Homero Vallada; Gerome Breen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.